WASHINGTON—The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc.’s challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication. The justices turned away Israel-based Teva’s appeal of a lower court’s ruling reinstating the jury award for U.K.-based GSK. The case involves…
Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute
Drug Maker Teva Reaches Proposed $4.25 Billion Settlement Over Alleged Role in Opioid Crisis
Pharmaceutical company Teva has agreed in principle to pay $4.25 billion after reaching a nationwide settlement with multiple states and local governments over its alleged role in the U.S. opioid crisis. The Israeli-based pharma giant on July 26 announced the agreement, which is set to end thousands of lawsuits filed against the company. The announcement came ahead of the company’s…
San Francisco Reaches $58 Million Opioid Settlement With Teva, Allergan
Teva Pharmaceutical Industries and AbbVie’s Allergan unit on Tuesday reached a $58 million settlement with the city of San Francisco just before completion of a trial over claims that they fueled an opioid epidemic in the city. Under the deal announced by City Attorney David Chiu, Israel-based Teva will pay $25 million in cash and…
Teva, Allergan Reach $161.5 Million Opioid Settlement With West Virginia
Teva Pharmaceutical Industries and AbbVie’s Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said Wednesday. The agreement is the largest state-negotiated settlement in West Virginia history, and consists of $134 million in cash plus the contribution of drugs…
Walgreens, Teva Accused of Fueling Opioid Addiction in Quest for New Markets
Walgreens Boots Alliance and Teva Pharmaceutical Industries Ltd. ignored the health risks when they created new markets for opioids, a lawyer for the city of San Francisco told a judge on Monday during opening statements of the first trial to target manufacturers, distributors, and pharmacies over the addictive pain medicines. Richard Heimann, a lawyer for…
Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the United States. The verdict, which followed a nearly six-month New York state court trial in a case brought by the state and two of…
Teva Settles Shareholder Lawsuit Over Generic Drug Pricing for $420 Million
Teva Pharmaceutical Industries Ltd. has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive scheme to fix the price of generic drugs. The settlement was disclosed on Tuesday in papers filed in federal court in Connecticut. The company did not admit to wrongdoing. Teva spokesperson Kelley Dougherty said the…
Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the United States. The verdict, which followed a nearly six-month New York state court trial in a case brought by the state and two of…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta